In mice, TNAP knockdown improved post-MI cardiac function and reduced fibrosis, while TNAP overexpression worsened cardiac function, validating TNAP as a therapeutic target for fibrotic disease [73]. This evidence concerns the gene ALPL and myocardial infarction.